Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/61145
Title: Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2
Authors: Gustavo H. Kijak
Sodsai Tovanabutra
Eric Sanders-Buell
Veerachai Watanaveeradej
Mark S. de Souza
Kenrad E. Nelson
Vidhaya Ketsararat
Vilawan Gulgolgarn
Manu Wera-arpachai
Somchai Sriplienchan
Chirasak Khamboonrueng
Deborah L. Birx
Merlin L. Robb
Francine E. McCutchan
Keywords: Immunology and Microbiology
Medicine
Issue Date: 5-Feb-2007
Abstract: High-resolution HIV-1 genotyping of large sample sets is crucial to define the evolving and dynamic epidemics in Asia. Here we present MHAbce v.2, a multi-region hybridization assay that individually discriminates subtypes B, C, CRF01_AE, and virtually all of their described recombinants, based on real-time PCR using subtype-specific TaqMan probes in 8 regions throughout the viral genome. In a validation panel (n = 70), the assay performed with a sensitivity of 95.7% and specificity of 99.8%. The assay was field-tested on samples from a retrospective MTCT cohort (n = 180; Lampang Province, Northern Thailand; 1996-1998). 177/180 of the samples were typeable, and 94.4% were typed as CRF01_AE. The remaining strains represented even proportions of subtype B and B/CRF01_AE recombinants and were confirmed by sequencing, revealing early links between the heterosexual and IDU HIV-1 epidemics in Thailand. MHAbce v.2, with an area of application including China, India, Southeast Asia, and the Pacific Rim, can be used to develop a comprehensive and detailed picture of this important component of the HIV/AIDS pandemic.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846088566&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/61145
ISSN: 10960341
00426822
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.